Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

被引:358
作者
Yoshimura, K
Aoki, H
Ikeda, Y
Fujii, K
Akiyama, N
Furutani, A
Hoshii, Y
Tanaka, N
Ricci, R
Ishihara, T
Esato, K
Hamano, K
Matsuzaki, M
机构
[1] Yamaguchi Univ, Sch Med, Dept Mol Cardiovasc Biol, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Cardiovasc Surg, Ube, Yamaguchi 7558505, Japan
[3] Yamaguchi Univ, Sch Med, Dept Pathol 1, Ube, Yamaguchi 7558505, Japan
[4] Yamaguchi Univ, Sch Med, Dept Radiol, Ube, Yamaguchi 7558505, Japan
[5] ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland
[6] Yamaguchi Univ, Sch Med, Dept Cardiovasc Med, Ube, Yamaguchi 7558505, Japan
关键词
D O I
10.1038/nm1335
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abdominal aortic aneurysm (AAA) is a common disease among elderly people that, when surgical treatment is inapplicable, results in progressive expansion and rupture of the aorta with high mortality. Although nonsurgical treatment for AAA is much awaited, few options are available because its molecular pathogenesis remains elusive. Here, we identify JNK as a proximal signaling molecule in the pathogenesis of AAA. Human AAA tissue showed a high level of phosphorylated JNK. We show that JNK programs a gene expression pattern in different cell types that cooperatively enhances the degradation of the extracellular matrix while suppressing biosynthetic enzymes of the extracellular matrix. Selective inhibition of JNK in vivo not only prevented the development of AAA but also caused regression of established AAA in two mouse models. Thus, JNK promotes abnormal extracellular matrix metabolism in the tissue of AAA and may represent a therapeutic target.
引用
收藏
页码:1330 / 1338
页数:9
相关论文
共 44 条
[1]   Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells [J].
Adachi, M ;
Katsumura, KR ;
Fujii, K ;
Kobayashi, S ;
Aoki, H ;
Matsuzaki, M .
FEBS LETTERS, 2003, 554 (1-2) :77-80
[2]   Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model [J].
Allaire, E ;
Forough, R ;
Clowes, W ;
Starcher, B ;
Clowes, AW .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1413-1420
[3]   Vascular smooth muscle cell endovascular therapy stabilizes already developed aneurysms in a model of aortic injury elicited by inflammation and proteolysis [J].
Allaire, E ;
Muscatelli-Groux, B ;
Guinault, AM ;
Pages, C ;
Goussard, A ;
Mandet, C ;
Bruneval, P ;
Méllière, D ;
Becquemin, JP .
ANNALS OF SURGERY, 2004, 239 (03) :417-427
[4]   Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes [J].
Aoki, H ;
Kang, PM ;
Hampe, J ;
Yoshimura, K ;
Noma, T ;
Matsuzaki, M ;
Izumo, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :10244-10250
[5]   Bistabillity in the JNK cascade [J].
Bagowski, CP ;
Ferrell, JE .
CURRENT BIOLOGY, 2001, 11 (15) :1176-1182
[6]   Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a prospective (Phase II) multicenter study [J].
Baxter, BT ;
Pearce, WH ;
Waltke, EA ;
Littooy, FN ;
Hallett, JW ;
Kent, KC ;
Upchurch, GR ;
Chaikof, EL ;
Mills, JL ;
Fleckten, B ;
Longo, GM ;
Lee, JK ;
Thompson, RW .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (01) :1-12
[7]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[8]   The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms [J].
Bigatel, DA ;
Elmore, JR ;
Carey, DJ ;
Cizmeci-Smith, G ;
Franklin, DP ;
Youkey, JR .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (01) :130-138
[9]   Increased amount of type III pN-collagen in AAA when compared with AOD [J].
Bode, MK ;
Mosorin, M ;
Satta, J ;
Risteli, L ;
Juvonen, T ;
Risteli, J .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2002, 23 (05) :413-420
[10]   A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].
Borsello, T ;
Clarke, PGH ;
Hirt, L ;
Vercelli, A ;
Repici, M ;
Schorderet, DF ;
Bogousslavsky, J ;
Bonny, C .
NATURE MEDICINE, 2003, 9 (09) :1180-1186